Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study

PHASE3UnknownINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

August 27, 2019

Primary Completion Date

March 10, 2020

Study Completion Date

May 20, 2020

Conditions
Genital Wart Virus Infection
Interventions
DRUG

Betaglucin soluble gel 0.2%

With the prior informed consent of the 51 study participants, 5 grams of 0.2% soluble betaglucin gel will be self-applied every 12 hours for 5 days. Both groups will receive an unlabeled tube so that none of the study participants will know what topical treatments they are receiving.

DRUG

Imiquimod 5% cream

With the prior informed consent of the 51 study participants, 1 gram of 5% imiquimod will be self-applied once a day for 5 days. Both groups will receive an unlabeled tube so that neither study participant knows what topical treatments they are receiving.

Trial Locations (1)

14027

RECRUITING

Clínica San Dominic, Managua

Sponsors
All Listed Sponsors
collaborator

CALOX Laboratories

UNKNOWN

collaborator

Bioanalisis

UNKNOWN

lead

Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri

NETWORK